Multiple sclerosis patients given PBS lifeline amid drug pricing dispute
Life-changing drugs used to treat multiple sclerosis (MS) will remain subsidised for Australians as Labor pledges to resolve…
PBS dispute could leave MS patients with huge bills for crucial drugs Ocrevus and Kesimpta
A dispute over how Australia prices medicines has sparked fears 10,000 people with multiple sclerosis will be forced…
Broken PBS system behind failure to list Mounjaro for type 2 diabetics, according to Medicines Australia
Hundreds of thousands of Australians with diabetes will continue paying thousands of dollars a year for lifesaving medication…
Painkillers and HRT therapies among drugs not being subsidised under PBS
Patients are being hit with excessive costs on a range of everyday prescription medicines because of flaws in…
Weight loss drug Wegovy to be listed on PBS
Wegovy will be heavily subsidised for Australians with severe obesity, who have also experienced a cardiovascular event, like…
Big change coming to cost of medicines
Prescriptions listed on the Pharmaceutical Benefits Scheme will be cut from $31.60 to $25 from January 1, 2026,…